SCHEMBL891113

SCHEMBL891113

CCCCCCCCCCCCCCCC(=O)CC(O)(CC)C(=O)CCCCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 11/20 0.50
▸ CES1 P23141 10/20 0.50
▸ CES2 O00748 5/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ MAPT P10636 1/20 0.47
▸ HAO1 Q9UJM8 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ SLC22A6 Q4U2R8 1/20 0.42
▸ SLC22A8 Q8TCC7 1/20 0.42
▸ GPR84 Q9NQS5 1/20 0.42
▸ PPARG P37231 1/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL591152 1.00 FAAH (0.50) FAAHCES1CES2KMT2AMEN1
Hydrochloric Acid SCHEMBL5049547 0.98 FAAH (0.48) FAAHCES1CES2KMT2AMEN1
Hydrochloric Acid SCHEMBL1942576 0.98 FAAH (0.48) FAAHCES1CES2KMT2AMEN1
SCHEMBL18025423 0.92 FAAH (0.53) FAAHCES1CES2KMT2AMEN1
SCHEMBL15056105 0.86 FAAH (0.47) FAAHCES1CES2KMT2AMEN1
SCHEMBL2250841 0.83 KMT2A (0.48) CES1CES2KMT2AMEN1HSD17B10
SCHEMBL13301754 0.78 FAAH (0.48) FAAHCES1CES2KMT2AMEN1
SCHEMBL2998537 0.77 FAAH (0.53) FAAHCES1CES2KMT2AMEN1
SCHEMBL28246114 0.76 KMT2A (0.50) KMT2AMEN1HSD17B10MAPTHAO1
SCHEMBL2128149 0.76 FAAH (0.57) FAAHCES1CES2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1703890-B1 PEARLIZER CONCENTRATE AND ITS USE IN PERSONAL CARE COMPOSITIONS RHODIA (US) 2010-11-17 — — EP claimed
US-11969492-B2 Composition and method for shaping or altering the shape of hair, method for manufacturing a composition, kit and uses of a composition L'OREAL (FR) 2024-04-30 — — US disclosed
WO-2023194511-A1 COMPOSITION FOR THE COSMETIC TREATMENT OF KERATIN FIBERS BIOSYNTHIS (FR) 2023-10-12 — — WO disclosed
US-11534378-B2 Hair coloring compositions BEAUTY & BUSINESS S.P.A. (IT) 2022-12-27 — — US disclosed
US-11389496-B2 Antifungal compositions BIOKOSMES SRL (IT) 2022-07-19 — — US disclosed
EP-4017455-A1 STABLE LOW pH PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME Colgate-Palmolive Company (US) 2022-06-29 — — EP disclosed
US-20220162234-A1 BORATE ESTER COMPLEXES OF A-HYDROXY CARBOXYLIC ACIDS AND THEIR CONJUGATE BASE BUFFERS MEDTECH PRODUCTS INC. 2022-05-26 — — US disclosed
US-20210393492-A1 COMPOSITION AND METHOD FOR SHAPING OR ALTERING THE SHAPE OF HAIR, METHOD FOR MANUFACTURING A COMPOSITION, KIT AND USES OF A COMPOSITION L'OREAL (FR) 2021-12-23 — — US disclosed
EP-3854422-A1 BIOMATERIAL FUJIFILM Corporation (JP) 2021-07-28 — — EP disclosed
US-20210196826-A1 BIOMATERIAL FUJIFILM CORPORATION (JP) 2021-07-01 — — US disclosed
WO-2006023548-A2 LOW PH STRUCTURED SURFACTANT COMPOSITIONS RHODIA INC. (US) 2006-03-02 — — WO disclosed
US-20050169877-A1 Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof L'OREAL (FR) 2005-08-04 — — US disclosed
EP-1349911-A1 DISPERSIONS OF NANOPARTICULATE FRAGRANCE-CONTAINING COMPOSITE MATERIALS Henkel Kommanditgesellschaft auf Aktien (DE) 2003-10-08 — — EP disclosed
US-6528070-B1 Emulsification system comprising a mixture of at least one cationic surfactant, at least one anionic surfactant, at least one \"bridging surfactant\", an oil and water, along with methods for preparing such emulsions. Synergistic mixtures of STEPAN COMPANY 2003-03-04 — — US disclosed
US-6494920-B1 A CLEANING COMPOSITION FOR USE IN CLEANING TEXTILE, HAIR AND SKIN, THE COMPOSITION CONTAINING: (A) AN ESTERQUAT; AND (B) ALOE. COGNIS DEUTSCHLAND GMBH & CO. KG (DE) 2002-12-17 — — US disclosed
WO-2002050230-A1 DISPERSIONS OF NANOPARTICULATE FRAGRANCE-CONTAINING COMPOSITE MATERIALS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-06-27 — — WO disclosed
EP-1011609-A4 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORP (US) 2000-08-16 — — EP disclosed
EP-1011609-A1 COMPOSITIONS FOR COSMETIC APPLICATIONS MedLogic Global Corporation (US) 2000-06-28 — — EP disclosed
EP-1004355-A2 Use of esterquats as pigment dispersants Cognis Deutschland GmbH (DE) 2000-05-31 — — EP disclosed
WO-1998050005-A1 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORPORATION (US) 1998-11-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050169877-A1 Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof KRT18, KRTCAP2, CKAP4 FAAH 2946/4885CES1 4506/4885CES2 4765/4885
US-20210196826-A1 BIOMATERIAL PHOSPHO1, CCL5, LPCAT3 FAAH 483/4885CES1 829/4885CES2 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback